Six Indian companies working on COVID-19 vaccine, many challenges in finding a preventive: Experts
Nearly 70 'vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the novel coronavirus is unlikely to be ready for mass use before 2021.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | Coronavirus | COVID-19 | India Health | Pharmaceuticals | Vaccines